The Discounted Cash Flow (DCF) valuation of Australian Pharmaceutical Industries Ltd (API.AX) is 14.29 AUD. With the latest stock price at 1.53 AUD, the upside of Australian Pharmaceutical Industries Ltd based on DCF is 834.2%.
Based on the latest price of 1.53 AUD and our DCF valuation, Australian Pharmaceutical Industries Ltd (API.AX) is a buy. buying API.AX stocks now will result in a potential gain of 834.2%.
| Range | Selected | |
| WACC / Discount Rate | 4.8% - 7.0% | 5.9% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 7.47 - 125.27 | 14.29 |
| Upside | 388.3% - 8087.7% | 834.2% |